Skip to Content

Office of Research and Grant Development

Program Details

NIH: Collaborative Activities to Promote Metabolomics Research (Admin Supp) PA-15-030

Sponsor: NIH
Internal Deadline: 01/08/2015
Sponsor Deadline: 02/13/2015
Program Website

NIH: Collaborative Activities to Promote Metabolomics Research (Admin Supp) PA-15-030

This Administrative Supplement funding opportunity is part of the Common Fund Metabolomics Program created to increase and improve the nation’s ability to undertake metabolomics analyses in translational and clinical research. Metabolomics has great potential to advance our understanding of human diseases, but requires specialized expertise in metabolomics study design, technology, and data analysis and interpretation. This FOA supports supplemental funds to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to add a metabolomics approach to the existing Research Strategy for the project. In addition to enhancing the parent grant by adding metabolomics analyses, collaborative projects must include activities to increase the expertise of the biomedical research group in key aspects of metabolomics study design, analysis, and data interpretation.

All applicants are strongly encouraged to discuss potential requests with the awarding IC and with the Common Fund Metabolomics Scientific/Research contact listed below.

USC may only submit one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (whitejrw@mailbox.sc.edu) by January 8, 2015. In addition to the 2-page abstract, you should also submit a biosketch for the PI.

NIH indicates that a letter of intent is Not Applicable and a full proposal is due by February 13, 2015. For more information: http://grants.nih.gov/grants/guide/pa-files/PA-15-030.html

Office of Research and Grant Development


    Challenge the conventional. Create the exceptional. No Limits.

    ©